Literature DB >> 19466596

Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.

Weifeng Ding1, Shaoqing Ju, Shengyang Jiang, Li Zhu, Yueguo Wang, Huimin Wang.   

Abstract

APRIL, a member of the TNF superfamily, can induce cell proliferation and is overexpressed in most tumor tissues or cells. Nevertheless, it is still unknown about the effect of decreased levels of APRIL expression on tumor cells. In this study, we analyzed APRIL and HSPG expression in the colon carcinoma cell line, SW480 by Western blot and RT-PCR. And the up-regulation of APRIL and HSPG expression was found in SW480. We also observed that knockdown of APRIL levels in SW480, prominently reversed cell proliferation and partially resulted in senescence phenotypes. Furthermore, cellular senescence due to a decreased level of APRIL expression was associated with engagement of HSPG. Thus, our results suggest that low levels of APRIL play an essential role in cellular senescence via a HSPG-dependent signaling pathway in SW480.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466596     DOI: 10.1007/s12253-009-9172-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 2.  Mechanisms of cellular senescence in human and mouse cells.

Authors:  Koji Itahana; Judith Campisi; Goberdhan P Dimri
Journal:  Biogerontology       Date:  2004       Impact factor: 4.277

3.  SA beta Gal staining: biomarker or delusion.

Authors:  V J Cristofalo
Journal:  Exp Gerontol       Date:  2005-09-21       Impact factor: 4.032

4.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

5.  APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.

Authors:  W Roth; B Wagenknecht; A Klumpp; U Naumann; M Hahne; J Tschopp; M Weller
Journal:  Cell Death Differ       Date:  2001-04       Impact factor: 15.828

6.  BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

Authors:  Viktor Roschke; Svetlana Sosnovtseva; Christopher D Ward; June S Hong; Rodger Smith; Vivian Albert; William Stohl; Kevin P Baker; Stephen Ullrich; Bernardetta Nardelli; David M Hilbert; Thi-Sau Migone
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

Review 7.  Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

Authors:  Upasna Gaur; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

8.  APRIL-deficient mice have normal immune system development.

Authors:  Eugene Varfolomeev; Frank Kischkel; Flavius Martin; Dhaya Seshasayee; Hua Wang; David Lawrence; Christine Olsson; Lucrece Tom; Sharon Erickson; Dorothy French; Peter Schow; Iqbal S Grewal; Avi Ashkenazi
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.

Authors:  P Rennert; P Schneider; T G Cachero; J Thompson; L Trabach; S Hertig; N Holler; F Qian; C Mullen; K Strauch; J L Browning; C Ambrose; J Tschopp
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Authors:  M Hahne; T Kataoka; M Schröter; K Hofmann; M Irmler; J L Bodmer; P Schneider; T Bornand; N Holler; L E French; B Sordat; D Rimoldi; J Tschopp
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  2 in total

1.  The TNF family member APRIL promotes colorectal tumorigenesis.

Authors:  V Lascano; L F Zabalegui; K Cameron; M Guadagnoli; M Jansen; M Burggraaf; M Versloot; H Rodermond; C van der Loos; C E Carvalho-Pinto; H Kalthoff; J P Medema; M Hahne
Journal:  Cell Death Differ       Date:  2012-06-15       Impact factor: 15.828

2.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.